Benefits of nirmatrelvir-ritonavir remain unproven for some populations

被引：0
|
作者：
McDonald, Emily G. [1 ]
Lee, Todd [1 ]
机构：
[1] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2022年 / 194卷 / 29期
关键词：
D O I：
10.1503/cmaj.146689-l
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1041 / E1041
页数：1
相关论文
共 50 条
  • [41] Response to "A Case Report of Safe Coadministration of Amioradone With Short-Term Treatment Nirmatrelvir-Ritonavir"
    Marzolini, Catia
    Khoo, Saye
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (04) : 770 - 770
  • [42] Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
    Vazquez, Sara R.
    Wilson, Aaron S.
    Witt, Daniel M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (04) : 583 - 586
  • [43] Nirmatrelvir-ritonavir treatment on SARS-CoV-2 viral dynamics in high altitude habitants
    Lu, Aili
    Zhou, Xuefu
    Han, Daoping
    Tang, Lu
    Rong, Xuping
    Zheng, Yulan
    Hong, Peng
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 30
  • [44] Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019
    Park, Hailey J.
    Tan, Sophia T.
    Leon, Tomas M.
    Jain, Seema
    Schechter, Robert
    Lo, Nathan C.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (09):
  • [45] Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
    Sara R. Vazquez
    Aaron S. Wilson
    Daniel M. Witt
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 583 - 586
  • [46] Effectiveness of molnupiravir and nirmatrelvir-ritonavir in patients hospitalized with COVID-19: A target trial emulation study
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Mok, Anna Hoi Ying
    Chan, Esther Wai Yin
    Wong, Ian Chi Kei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 264 - 264
  • [47] Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19
    Zeng, Guangting
    Wang, Linlin
    Li, Jianqiang
    Zhang, Zanling
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [48] The effect of nirmatrelvir-ritonavir on the long-term risk of neuropsychiatric sequelae following COVID-19
    Liu, Ting-Hui
    Wu, Jheng-Yan
    Huang, Po-Yu
    Tsai, Ya-Wen
    Lai, Chih-Cheng
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (07)
  • [49] Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2
    Devresse, Arnaud
    Briol, Sebastien
    De Greef, Julien
    Lemaitre, Florian
    Boland, Lidvine
    Haufroid, Vincent
    Scohy, Anais
    Kabamba, Benoit
    Yombi, Jean Cyr
    Belkhir, Leila
    Darius, Tom
    Buemi, Antoine
    De Potter, Kristell
    Mantegazza, Rebecca
    Bearzatto, Bertrand
    Goffin, Eric
    Kanaan, Nada
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (11): : 2356 - 2363
  • [50] Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system
    Malden, Deborah E.
    Mclaughlin, John M.
    Hong, Vennis
    Lewnard, Joseph
    Ackerson, Bradley K.
    Puzniak, Laura
    Kim, Jeniffer S.
    Takhar, Harpreet
    Frankland, Timothy B.
    Slezak, Jeff M.
    Tartof, Sara Y.
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345